1347 GMT - The consumer-health industry could see more merger-and-acquisition activity, but smaller deals for certain brands or segments seem more likely than large-scale takeovers, Citi analysts say in a research note. Recent spinoffs such as Kenvue and Haleon, potential splits or asset reviews at Bayer and Reckitt Benckiser, and acquisition attempts like Unilever's for Haleon in 2022 left investors wondering whether the industry could consolidate, Citi says. Healthy balance sheets and interest from the likes of Procter & Gamble suggest there is room for acquisitions, but antitrust concerns and diverse portfolios make large deals unlikely, Citi says. In a large takeover, the buyer would probably need a significant portfolio reshaping afterward, the analysts say. The Stoxx Europe 600 Personal & Household Goods index is up 0.6%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

May 30, 2025 09:47 ET (13:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.